SURFACE-PROPERTIES OF SUPERPARAMAGNETIC IRON-OXIDE MR CONTRAST AGENTS - FERUMOXIDES, FERUMOXTRAN, FERUMOXSIL

被引:205
|
作者
JUNG, CW
机构
[1] Advanced Magnetics, Inc., Cambridge
关键词
SUPERPARAMAGNETIC IRON OXIDE; CONTRAST AGENTS; FERUMOXIDES; FERUMOXTRAN; FERUMOXSIL; DEXTRAN;
D O I
10.1016/0730-725X(95)00023-A
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The surface properties of the active ingredients in AMI colloidal, superparamagnetic iron oxide magnetic resonance (MR) contrast agents are described. Scanning electron microscopy/energy dispersive X-ray elemental analyses and diffuse reflectance Fourier transform infrared spectroscopy (FTIR) spectra of ferumoxsil (AMI-121 drug substance) were consistent with the presence of a monolayer of H2NCH2CH2NHCH2CH2CH2Si(O-)(3) siloxane monomer or dimer. The X-ray photoelectron spectra (XPS) of ferumoxsil are also consistent with complete coverage of the iron oxide surface with a monolayer of siloxane. The static secondary ion mass spectra (SSIMS) of ferumoxsil showed that the siloxane film is covalently bonded (i.e., Si-O-Fe bonds) to the iron oxide surface. The FTIR of ferumoxides (AMI-25) and Ferumoxtran (AMI-227) showed only adsorbed dextran. The XPS spectra of the dextran-coated colloids showed that Ferumoxtran has a thicker layer of dextran than ferumoxides iron oxide particles (similar to 5 and similar to 3 nm, respectively). The SSIMS spectra of these dextran-coated colloids showed only low mass fragments due to the adsorbed dextran. The nature of the interactions of the dextran coating with the iron oxide surfaces of ferumoxides and Ferumoxtran is discussed.
引用
收藏
页码:675 / 691
页数:17
相关论文
共 50 条
  • [31] INTRAVENOUS MR LYMPHOGRAPHY WITH SUPERPARAMAGNETIC IRON-OXIDE PARTICLES - EXPERIMENTAL STUDIES IN RATS AND RABBITS
    WAGNER, S
    PFEFFERER, D
    EBERT, W
    KRESSE, M
    TAUPITZ, M
    HAMM, B
    LAWACZECK, R
    SEMMLER, W
    WOLF, KJ
    EUROPEAN RADIOLOGY, 1995, 5 (06) : 640 - 646
  • [33] LIVER METASTASES - SAFETY AND EFFICACY OF DETECTION WITH SUPERPARAMAGNETIC IRON-OXIDE IN MR-IMAGING
    BELLIN, MF
    ZAIM, S
    AUBERTON, E
    SARFATI, G
    DURON, JJ
    KHAYAT, D
    GRELLET, J
    RADIOLOGY, 1994, 193 (03) : 657 - 663
  • [34] LOCALIZATION OF P-31 MR SIGNAL WITH USE OF SUPERPARAMAGNETIC IRON-OXIDE PARTICLES
    ENGELSTAD, BL
    WHITE, DL
    MOSELEY, ME
    STARK, DD
    RADIOLOGY, 1990, 176 (02) : 467 - 472
  • [35] SUPERPARAMAGNETIC IRON-OXIDE USED AS A CONTRAST AGENT FOR MR IMAGING (MRI) IN MALIGNANT LIVER-TUMORS - A PRELIMINARY-STUDY
    GUYADER, D
    GANDON, Y
    BRUNET, F
    CARSIN, M
    ARTHAUD, A
    BONNEMAIN, B
    SIMON, J
    BRISSOT, P
    DEUGNIER, Y
    HEPATOLOGY, 1989, 10 (04) : 673 - 673
  • [36] Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection
    Shahbazi-Gahrouei, Daryoush
    Abdolahi, Mohammad
    JOURNAL OF MEDICAL PHYSICS, 2013, 38 (04) : 198 - 204
  • [37] Peptide functionalized superparamagnetic iron oxide nanoparticles as MRI contrast agents
    Sulek, Selim
    Mammadov, Busra
    Mahcicek, Davut I.
    Sozeri, Huseyin
    Atalar, Ergin
    Tekinay, Ayse B.
    Guler, Mustafa O.
    JOURNAL OF MATERIALS CHEMISTRY, 2011, 21 (39) : 15157 - 15162
  • [38] Zinc superparamagnetic iron oxide nanoparticles for use as MRI contrast agents
    Barcena, Carlos
    Kherntong, Chalermchai
    Chaubey, Girija S.
    Kessinger, Chase W.
    Liu, J. Ping
    Gao, Jinming
    PROCEEDING OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2007, 2007, : 49 - 50
  • [39] Impact of metallic trace elements on relaxivities of iron-oxide contrast agents
    Ma, Ji
    Chen, Kezheng
    RSC ADVANCES, 2019, 9 (53) : 30932 - 30936
  • [40] 1ST CLINICAL-TRIAL OF A NEW SUPERPARAMAGNETIC IRON-OXIDE FOR USE AS AN ORAL GASTROINTESTINAL CONTRAST AGENT IN MR IMAGING
    HAHN, PF
    STARK, DD
    LEWIS, JM
    SAINI, S
    ELIZONDO, G
    WEISSLEDER, R
    FRETZ, CJ
    FERRUCCI, JT
    RADIOLOGY, 1990, 175 (03) : 695 - 700